miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/Ritonavir

• Ngā kaituhi matua: Elena Bresciani (Author), Cecilia Saletti (Author), Nicola Squillace (Author), Laura Rizzi (Author), Laura Molteni (Author), Ramona Meanti (Author), Robert J. Omeljaniuk (Author), Giuseppe Biagini (Author), Andrea Gori (Author), Vittorio Locatelli (Author), Antonio Torsello (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2019-04-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Metabolic complications represent a common and serious problem associated with HIV infection and combined Antiretroviral Therapy (cART). Alterations in body fat distribution are associated with significantly increased risks of (i) metabolic derangements, (ii) cardiovascular pathologies,...